Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Marla, Daves"'
Autor:
Anna L. Hoppmann, Chen Dai, Marla Daves, Hamayun Imran, Kimberly Whelan, Kelly Kenzik, Smita Bhatia
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
Background: One-fifth of U.S. counties are designated persistent child poverty counties (≥20% of children in poverty since 1980). The association between a persistent child poverty environment and mortality in children with cancer is unknown. Metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38cb60a31c492a71e3fb0b6e651d1221
https://pubmed.ncbi.nlm.nih.gov/36129811
https://pubmed.ncbi.nlm.nih.gov/36129811
Autor:
Rochelle Bagatell, Yuan-Shun V Huang, Tamara P. Miller, Jessica A. Pollard, Kelly D. Getz, Alix E. Seif, Terzah M. Horton, Selina M. Luger, Todd A. Alonzo, Richard Aplenc, Lillian Sung, Brian T. Fisher, Alan S. Gamis, Robert B. Gerbing, Marla Daves, Yimei Li, Peter C. Adamson, Michael A. Pulsipher, Marko Kavcic
Publikováno v:
Haematologica. 102:e340-e343
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba95cf0324d467639f24482099bd40df
https://doi.org/10.3324/haematol.2017.168815
https://doi.org/10.3324/haematol.2017.168815
Autor:
Jennifer Miller, Tim J. Porea, Tara Wright, Matthew A. Musick, Sara Anvari, Mona D. Shah, Jennifer Foster, Marla Daves, Nicholas L. Rider
Publikováno v:
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology. 30(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55cdb931ff287405bb4c8ee1bff950a3
https://pubmed.ncbi.nlm.nih.gov/30963632
https://pubmed.ncbi.nlm.nih.gov/30963632
Autor:
Yimei Li, Alan S. Gamis, Tamara P. Miller, Andrea B. Troxel, Michael A. Pulsipher, Terzah M. Horton, Jessica A. Pollard, Selina M. Luger, Peter C. Adamson, Marko Kavcic, Richard Aplenc, Lillian Sung, Brian T. Fisher, Marla Daves, Rochelle Bagatell, Yuan Shun V Huang, Todd A. Alonzo, Matthew Hall, Alix E. Seif, Robert B. Gerbing
Publikováno v:
Journal of Clinical Oncology. 34:1537-1543
Purpose Reporting of adverse events (AEs) in clinical trials is critical to understanding treatment safety, but data on AE accuracy are limited. This study sought to determine the accuracy of AE reporting for pediatric acute myeloid leukemia clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f20967347fd35b5f14d29192878d4ee4
https://doi.org/10.1200/jco.2015.65.5860
https://doi.org/10.1200/jco.2015.65.5860
Autor:
William L. Carroll, Gabriel A. Robbins, Cynthia Loomis, Yuling Dai, Iannis Aifantis, Kathryn G. Roberts, Anastasia N. Tikhonova, Chao Ma, Chunxu Qu, Igor Dolgalev, Nikki A. Evensen, Deqing Pei, Aristotelis Tsirigos, Cheng Cheng, Michael E. Scheurer, Shanmugapriya Selvaraj, Karen R. Rabin, Marla Daves, Audrey Lasry, Charles G. Mullighan, Sheetal Sreeram, Valeria Mezzano, Joanna Pierro, Tiffany Chambers, Weiqiang Chen, Philip J. Lupo, Matthew T. Witkowski
Publikováno v:
Cancer Cell
Summary A subset of B cell acute lymphoblastic leukemia (B-ALL) patients will relapse and succumb to therapy-resistant disease. The bone marrow microenvironment may support B-ALL progression and treatment evasion. Utilizing single-cell approaches, we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89797ea734523a2caae12da541fe7692
https://doi.org/10.1016/j.ccell.2020.04.015
https://doi.org/10.1016/j.ccell.2020.04.015
Autor:
Kelly D. Getz, Karen R. Rabin, Maria M. Gramatges, Richard Aplenc, Michael E. Scheurer, Tiffany M. Chambers, Evanette Burrows, Philip J. Lupo, Joanna S. Yi, Tamara P. Miller, Marla Daves
Publikováno v:
Blood. 134:3814-3814
Introduction: Hepatotoxicity is a frequent and challenging adverse event in children with acute lymphoblastic leukemia (ALL), but patient factors that are predictive of hepatotoxicity are not well understood. We leveraged a data repository jointly de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ff9997097b1dd52c65d1b13ed235011
https://doi.org/10.1182/blood-2019-123992
https://doi.org/10.1182/blood-2019-123992
Autor:
Biniyam Demissei, Richard Aplenc, Kelly D. Getz, Karen R. Rabin, Philip J. Lupo, Tamara P. Miller, Marla Daves, Lena E. Winestone, Jennifer J. Wilkes, Maria M. Gramatges, Judy Lee, Robert W. Grundmeier, Evanette Burrows, Brian T. Fisher, Michael E. Scheurer
Publikováno v:
Blood. 134:333-333
Introduction: Adverse events (AEs) are often under- or misreported on clinical trials, leading to an incomplete understanding of therapy-associated toxicities. We previously demonstrated that laboratory result data can be extracted from the electroni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c981fe0fc0653464af10b896d5e5c448
https://doi.org/10.1182/blood-2019-130656
https://doi.org/10.1182/blood-2019-130656
Autor:
Glen Lew, Marla Daves, Frank G. Keller, Robert Sheppard Nickel, Todd Cooper, John Bergsagel, Himalee S. Sabnis
Publikováno v:
Pediatric Blood & Cancer. 61:810-814
Background Daunorubicin, a component of the four-drug induction chemotherapy regimen for de novo pediatric high-risk acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LLy), was unavailable in 2011 due to a national drug shortage. During
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12948abd05a66a7815a1452777b683fb
https://doi.org/10.1002/pbc.24892
https://doi.org/10.1002/pbc.24892
Autor:
Tamara P. Miller, Kelly D. Getz, Yuan Shun V Huang, Marla Daves, Yimei Li, Terzah M. Horton, Richard Aplenc, Lillian Sung, Brian T. Fisher, Marko Kavcic, Alan S. Gamis, Alix E. Seif, Jessica Pollard, Michael A. Pulsipher, Robert B. Gerbing, Todd A. Alonzo, Rochelle Bagatell
Publikováno v:
Leukemialymphoma. 57(7)
While most children receive acute myeloid leukemia (AML) chemotherapy as inpatients, there is variability in timing of discharge after chemotherapy completion. This study compared treatment-related morbidity, mortality and cumulative hospitalization
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48a2663f44c60652070b2ed940569e7c
https://pubmed.ncbi.nlm.nih.gov/26727639
https://pubmed.ncbi.nlm.nih.gov/26727639
Autor:
Philip J. Lupo, Michael E. Scheurer, M. Monica Gramatges, Kelly D. Getz, Evanette Burrows, Karen R. Rabin, Richard Aplenc, Tiffany Simone Chambers, Joanna S. Yi, Marla Daves
Publikováno v:
Blood. 132:1383-1383
Introduction: Hepatotoxicity is a challenging adverse event associated with acute lymphoblastic leukemia (ALL) therapy. Due to a lack of large, diverse, and well-characterized cohorts in pediatric ALL, factors predictive of therapy-related adverse ev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::11ae7f8a2f95d30ba12cc12487e63d02
https://doi.org/10.1182/blood-2018-99-115691
https://doi.org/10.1182/blood-2018-99-115691